---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-371260"
form_type: "8-K"
ticker: "RNTX"
cik: "0001420565"
company_name: "Rein Therapeutics, Inc."
filed_at: "2026-08-27T20:05:28+00:00"
generated_at: "2026-08-27T20:08:34.948711+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Rein Therapeutics receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Received delisting notice from Nasdaq on Aug 21, 2026 for bid price below $1.00 for 30 consecutive trading days.
- Has 180 days, until Feb 17, 2027, to regain compliance with minimum bid price rule.
- Must achieve closing bid of at least $1.00 for 10 consecutive business days to cure.
- May be eligible for additional time if meeting other Capital Market listing standards, but no assurance given.

## SEC filing metadata
- accession: 0001193125-26-371260
- form_type: 8-K
- ticker: RNTX
- cik: 0001420565
- company_name: Rein Therapeutics, Inc.
- filed_at: 2026-08-27T20:05:28+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420565/000119312526371260/0001193125-26-371260-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420565/000119312526371260/d154403d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-371260
- JSON: https://secwatch.observer/filing/0001193125-26-371260.json
- Plain text: https://secwatch.observer/filing/0001193125-26-371260.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.